Stergiou Angelos M. 4
4 · SELLAS Life Sciences Group, Inc. · Filed Dec 5, 2025
Insider Transaction Report
Form 4
Stergiou Angelos M.
DirectorPresident and CEO
Transactions
- Other
Common Stock
2025-12-03$1.50/sh−187,066$280,599→ 686,966 total
Footnotes (2)
- [F1]Transaction relates to shares of common stock withheld by the SELLAS Life Sciences Group, Inc. (the "Issuer") to cover tax withholding obligations of the Reporting Person in connection with the vesting of Restricted Stock Units ("RSUs").
- [F2]Represents the number shares of common stock withheld by the Issuer to cover tax withholding obligations of the Reporting Person in connection with the vesting of RSUs.